Efficacy and Safety of Botulinum Toxin A for Treating Bladder Hyperactivity in Children and Adolescents with Neuropathic Bladder Secondary to Myelomeningocele

<table>Demographic data graph before and after the first injection of BTX-A. LPV: leak point volume; LPP: leak point pressure; SC: specific capacity at 20 cm H<sub>2</sub>O.</table>

Dataset Papers in Science

fig4

Figure 4

Figure 4: Efficacy and Safety of Botulinum Toxin A for Treating Bladder Hyperactivity in Children and Adolescents with Neuropathic Bladder Secondary to Myelomeningocele 

Figure 4 | Efficacy and Safety of Botulinum Toxin A for Treating Bladder Hyperactivity in Children and Adolescents with Neuropathic Bladder Secondary to Myelomeningocele 